Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|February 22, 2012
A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's diseaseJean-Marie Serot, Jadwiga Zmudka, Pierre Jouanny
Frontiers in Bioscience : a Journal and Virtual Library|April 18, 2003
Choroid plexus, aging of the brain, and Alzheimer's diseaseJean-Marie Serot, Marie-Christine Béné, Gilbert C Faure
Geriatrics & Gerontology International|May 9, 2015
In geriatric patients, delirium symptoms are related to the anticholinergic burdenMoustafa Naja, Jadwiga Zmudka, Sanaa Hannat, et al.
Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|September 24, 2015
[Fragility assessment in primary care: which tools for predicting what?]Flavie Gleize, Jadwiga Zmudka, Yoann Lefresne, et al.
Frontiers in Aging Neuroscience|July 23, 2016
Interactions between Flow Oscillations and Biochemical Parameters in the Cerebrospinal FluidVincent Puy, Jadwiga Zmudka-Attier, Cyrille Capel, et al.
Journal of the American Geriatrics Society|January 20, 2015
Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitudeOarda Bahri, Frederic Roca, Tarik Lechani, et al.
Fluids and Barriers of the CNS|February 26, 2011
Cerebrospinal fluid and blood flow in mild cognitive impairment and Alzheimer's disease: a differential diagnosis from idiopathic normal pressure hydrocephalusSoraya El Sankari, Catherine Gondry-Jouet, Anthony Fichten, et al.
BMC Neuroscience|May 17, 2011
Reduced CSF turnover and decreased ventricular Aβ42 levels are relatedJean-Marie Serot, Johann Peltier, Antony Fichten, et al.
Neuroscience Letters|August 30, 2003
Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope studyBrigitte Leininger-Muller, Aline Hoy, Bernard Herbeth, et al.
Expert Review of Neurotherapeutics|September 23, 2009
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Roxana Oprisiu-Fournier, Sébastien Faure, Hakim Mazouz, et al.
Pageof 2